|
US6749853B1
(en)
|
1992-03-05 |
2004-06-15 |
Board Of Regents, The University Of Texas System |
Combined methods and compositions for coagulation and tumor treatment
|
|
GB9324807D0
(en)
|
1993-12-03 |
1994-01-19 |
Cancer Res Campaign Tech |
Tumour antibody
|
|
DE69519929T2
(de)
|
1994-07-11 |
2001-05-23 |
Board Of Regents, The University Of Texas System |
Verfahren und zusammensetzungen für die spezifische koagulation von tumorgefässen
|
|
US6117980A
(en)
|
1997-02-21 |
2000-09-12 |
Genentech, Inc. |
Humanized anti-IL-8 monoclonal antibodies
|
|
US20030109680A1
(en)
|
2001-11-21 |
2003-06-12 |
Sunol Molecular Corporation |
Antibodies for inhibiting blood coagulation and methods of use thereof
|
|
US20060235209A9
(en)
|
1997-03-10 |
2006-10-19 |
Jin-An Jiao |
Use of anti-tissue factor antibodies for treating thromboses
|
|
JP2001206899A
(ja)
|
1999-11-18 |
2001-07-31 |
Japan Tobacco Inc |
ＴＧＦ−βＩＩ型受容体に対するヒトモノクローナル抗体及びその医薬用途
|
|
AU2270101A
(en)
|
1999-12-20 |
2001-07-03 |
Merck & Co., Inc. |
Pharmaceutical kit
|
|
AU2001239470A1
(en)
|
2000-02-24 |
2001-09-03 |
Philogen S.R.L. |
Compositions and methods for treatment of angiogenesis in pathological lesions
|
|
AU2001259215A1
(en)
|
2000-04-28 |
2001-11-12 |
La Jolla Institute For Allergy And Immunology |
Human anti-cd40 antibodies and methods of making and using same
|
|
US7083784B2
(en)
|
2000-12-12 |
2006-08-01 |
Medimmune, Inc. |
Molecules with extended half-lives, compositions and uses thereof
|
|
DK1345969T3
(da)
|
2000-12-26 |
2010-11-29 |
Inst Nat Sante Rech Med |
Anti-CD28-antistof
|
|
US20040204481A1
(en)
|
2001-04-12 |
2004-10-14 |
Pnina Fishman |
Activation of natural killer cells by adenosine A3 receptor agonists
|
|
WO2003015697A2
(en)
|
2001-08-13 |
2003-02-27 |
University Of Southern California |
Interleukin-2 mutants with reduced toxicity
|
|
TWI338009B
(en)
|
2001-10-29 |
2011-03-01 |
Genentech Inc |
Antibodies for inhibiting blood coagulation and methods of use thereof
|
|
AU2003239197A1
(en)
|
2002-06-07 |
2003-12-22 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of |
Novel stable anti-cd22 antibodies
|
|
US9321832B2
(en)
|
2002-06-28 |
2016-04-26 |
Domantis Limited |
Ligand
|
|
KR20120068769A
(ko)
|
2002-07-15 |
2012-06-27 |
더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 |
음이온성 인지질 및 아미노인지질에 결합하는 선택된 항체 및 치료하는데 있어서 이의 용도
|
|
US7482436B2
(en)
|
2002-08-30 |
2009-01-27 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
Human antihuman interleukin-6 antibody and fragment of antibody
|
|
EP1400534B1
(en)
|
2002-09-10 |
2015-10-28 |
Affimed GmbH |
Human CD3-specific antibody with immunosuppressive properties
|
|
CN101899114A
(zh)
|
2002-12-23 |
2010-12-01 |
惠氏公司 |
抗pd-1抗体及其用途
|
|
US7563869B2
(en)
|
2003-01-23 |
2009-07-21 |
Ono Pharmaceutical Co., Ltd. |
Substance specific to human PD-1
|
|
EP1599502A1
(en)
|
2003-02-27 |
2005-11-30 |
TheraVision GmbH |
A molecule which binds cd80 and cd86
|
|
CA2518854A1
(en)
|
2003-03-21 |
2004-10-07 |
Wyeth |
Treating immunological disorder using agonists of interleukin-21/interleukin-21 receptor
|
|
US7618632B2
(en)
|
2003-05-23 |
2009-11-17 |
Wyeth |
Method of treating or ameliorating an immune cell associated pathology using GITR ligand antibodies
|
|
US9005613B2
(en)
|
2003-06-16 |
2015-04-14 |
Immunomedics, Inc. |
Anti-mucin antibodies for early detection and treatment of pancreatic cancer
|
|
JP2005124568A
(ja)
|
2003-10-01 |
2005-05-19 |
Junichi Masuyama |
細胞活性化方法及びこれを用いる細胞製造方法並びに医薬組成物
|
|
NZ549040A
(en)
|
2004-02-17 |
2009-07-31 |
Schering Corp |
Use for interleukin-33 (IL33) and the IL-33 receptor complex
|
|
ES2375481T3
(es)
|
2004-03-30 |
2012-03-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Anticuerpos biespecíficos para elegir como diana células que participan en reacciones de tipo alérgico, composiciones y usos de los mismos.
|
|
TR201901929T4
(tr)
|
2005-02-08 |
2019-03-21 |
Genzyme Corp |
TGFBeta'ya antikorlar.
|
|
US7393833B2
(en)
|
2005-03-09 |
2008-07-01 |
The Board Of Regents Of The University Of Oklahoma |
Chimeric proteins with phosphatidylserine binding domains
|
|
DK1863905T3
(en)
|
2005-03-17 |
2016-04-04 |
Ucl Business Plc |
PROCEDURE FOR ACTIVATING NATURAL KILLER CELLS USING VITRO TUMOR CELL PREPARATIONS
|
|
CN100509849C
(zh)
|
2005-04-07 |
2009-07-08 |
苏州大学 |
可溶性人cd28分子检测试剂盒及其应用
|
|
JP5122441B2
(ja)
|
2005-04-19 |
2013-01-16 |
シアトル ジェネティックス， インコーポレイテッド |
ヒト化抗ｃｄ７０結合剤およびその使用
|
|
CA2763671A1
(en)
|
2005-04-26 |
2006-11-02 |
Pfizer Inc. |
P-cadherin antibodies
|
|
CA2607954A1
(en)
|
2005-05-11 |
2006-11-16 |
Philogen S.P.A. |
Conjugate for targeting of drug
|
|
GB0510790D0
(en)
|
2005-05-26 |
2005-06-29 |
Syngenta Crop Protection Ag |
Anti-CD16 binding molecules
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
EP1777294A1
(en)
|
2005-10-20 |
2007-04-25 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
IL-15Ralpha sushi domain as a selective and potent enhancer of IL-15 action through IL-15Rbeta/gamma, and hyperagonist (IL15Ralpha sushi -IL15) fusion proteins
|
|
US8092804B2
(en)
|
2007-12-21 |
2012-01-10 |
Medimmune Limited |
Binding members for interleukin-4 receptor alpha (IL-4Rα)-173
|
|
EP2604279A1
(en)
|
2008-03-27 |
2013-06-19 |
ZymoGenetics, Inc. |
Compositions and methods for inhibiting PDGFRBETA and VEGF-A
|
|
BRPI0914251B1
(pt)
|
2008-06-25 |
2022-07-19 |
Novartis Ag |
Imunoligante recombinante, seu fragmento de ligação ao antígeno, uso dos mesmos, e composição
|
|
CN102149825B
(zh)
|
2008-07-08 |
2015-07-22 |
Abbvie公司 |
前列腺素e2双重可变结构域免疫球蛋白及其用途
|
|
WO2010017103A2
(en)
|
2008-08-04 |
2010-02-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic |
Fully human anti-human nkg2d monoclonal antibodies
|
|
US8298533B2
(en)
|
2008-11-07 |
2012-10-30 |
Medimmune Limited |
Antibodies to IL-1R1
|
|
EP3255060A1
(en)
|
2008-12-09 |
2017-12-13 |
F. Hoffmann-La Roche AG |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
|
WO2011028811A2
(en)
|
2009-09-01 |
2011-03-10 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
|
DE102009045006A1
(de)
|
2009-09-25 |
2011-04-14 |
Technische Universität Dresden |
Anti-CD33 Antikörper und ihre Anwendung zum Immunotargeting bei der Behandlung von CD33-assoziierten Erkrankungen
|
|
BR112012008833A2
(pt)
|
2009-10-15 |
2015-09-08 |
Abbott Lab |
imunoglobulinas de dominio variavel duplo e usos das mesmas
|
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
KR20130036192A
(ko)
|
2010-02-11 |
2013-04-11 |
알렉시온 파마슈티칼스, 인코포레이티드 |
항-ｃｄ200 항체들을 이용한 치료 및 진단 방법
|
|
EP2560994B1
(en)
|
2010-04-08 |
2016-10-12 |
JN Biosciences LLC |
Antibodies to cd122
|
|
AU2011262758B8
(en)
|
2010-06-11 |
2014-09-04 |
Kyowa Kirin Co., Ltd. |
Anti-tim-3 antibody
|
|
EP3252072A3
(en)
|
2010-08-03 |
2018-03-14 |
AbbVie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
JP2012034668A
(ja)
|
2010-08-12 |
2012-02-23 |
Tohoku Univ |
ヒト型化抗ｅｇｆｒ抗体リジン置換可変領域断片及びその利用
|
|
US8507222B2
(en)
|
2010-09-21 |
2013-08-13 |
Altor Bioscience Corporation |
Multimeric IL-15 soluble fusion molecules and methods of making and using same
|
|
EP2627425A4
(en)
|
2010-10-11 |
2014-11-05 |
Abbvie Inc |
METHODS OF PURIFYING PROTEINS
|
|
CN102153653B
(zh)
|
2010-12-30 |
2012-08-15 |
厦门大学 |
肿瘤血管靶向多肽与组织因子的融合蛋白及其制备方法
|
|
GB201103955D0
(en)
|
2011-03-09 |
2011-04-20 |
Antitope Ltd |
Antibodies
|
|
US8476409B2
(en)
|
2011-04-19 |
2013-07-02 |
Merrimack Pharmaceuticals, Inc. |
Bispecific anti-IGF-1R and anti-ErbB3 antibodies
|
|
WO2012147713A1
(ja)
|
2011-04-25 |
2012-11-01 |
第一三共株式会社 |
抗ｂ７－ｈ３抗体
|
|
ES2765874T3
(es)
|
2011-05-25 |
2020-06-11 |
Innate Pharma Sa |
Anticuerpos anti-KIR para el tratamiento de trastornos inflamatorios
|
|
US8753640B2
(en)
|
2011-05-31 |
2014-06-17 |
University Of Washington Through Its Center For Commercialization |
MIC-binding antibodies and methods of use thereof
|
|
CN103732623B
(zh)
|
2011-06-03 |
2017-09-29 |
佐马技术有限公司 |
对TGF‑β具有特异性的抗体
|
|
WO2012170470A1
(en)
|
2011-06-06 |
2012-12-13 |
Board Of Regents Of The University Of Nebraska |
Compositions and methods for detection and treatment of cancer
|
|
ES2677367T3
(es)
|
2011-06-22 |
2018-08-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anticuerpos anti-Axl y usos de los mismos
|
|
EP2537933A1
(en)
|
2011-06-24 |
2012-12-26 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
An IL-15 and IL-15Ralpha sushi domain based immunocytokines
|
|
TWI495644B
(zh)
|
2011-11-11 |
2015-08-11 |
Rinat Neuroscience Corp |
營養層細胞表面抗原（Ｔｒｏｐ－２）之專一性抗體類及彼等之用途
|
|
EP2807292B1
(en)
|
2012-01-26 |
2019-05-22 |
Tecan Genomics, Inc. |
Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation
|
|
CA2866378A1
(en)
|
2012-03-08 |
2013-09-12 |
Selig Sealing Products, Inc. |
Container sealing member with protected security component and removal tab
|
|
KR101535341B1
(ko)
|
2012-07-02 |
2015-07-13 |
한화케미칼 주식회사 |
Dll4에 특이적으로 결합하는 신규한 단일클론항체 및 이의 용도
|
|
PE20150645A1
(es)
|
2012-08-08 |
2015-05-11 |
Roche Glycart Ag |
Proteinas de fusion de interleuquina 10 y usos de las mismas
|
|
WO2014026054A2
(en)
|
2012-08-10 |
2014-02-13 |
University Of Southern California |
CD20 scFv-ELPs METHODS AND THERAPEUTICS
|
|
CN104379169A
(zh)
|
2012-08-14 |
2015-02-25 |
Ibc药品公司 |
用于治疗疾病的t-细胞重定向双特异性抗体
|
|
EP2890713A1
(en)
|
2012-08-28 |
2015-07-08 |
Institut Curie |
Cluster of differentiation 36 (cd36) as a therapeutic target for hiv infection
|
|
DK3199552T3
(da)
|
2012-11-20 |
2020-03-30 |
Sanofi Sa |
Anti-ceacam5-antistoffer og anvendelser heraf
|
|
EP2931750B8
(en)
|
2012-12-17 |
2021-11-03 |
Cell Medica Inc. |
Antibodies against il-1 beta
|
|
WO2014116846A2
(en)
|
2013-01-23 |
2014-07-31 |
Abbvie, Inc. |
Methods and compositions for modulating an immune response
|
|
US9573988B2
(en)
|
2013-02-20 |
2017-02-21 |
Novartis Ag |
Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells
|
|
US9790274B2
(en)
|
2013-03-14 |
2017-10-17 |
The Board Of Regents Of The University Of Texas System |
Monoclonal antibodies targeting EpCAM for detection of prostate cancer lymph node metastases
|
|
CA2913052A1
(en)
|
2013-05-24 |
2014-11-27 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor-targeting monoclonal antibodies
|
|
JP2015030666A
(ja)
|
2013-07-31 |
2015-02-16 |
学校法人順天堂 |
抗ヒトｃｄ２６モノクローナル抗体又はその抗原結合性断片
|
|
JP2015054824A
(ja)
|
2013-09-10 |
2015-03-23 |
学校法人順天堂 |
Ｍｅｒｓコロナウイルス感染症予防治療剤
|
|
CN103709251B
(zh)
*
|
2013-12-19 |
2016-04-13 |
江苏众红生物工程创药研究院有限公司 |
全人源抗cd26抗体及其应用
|
|
KR102127408B1
(ko)
|
2014-01-29 |
2020-06-29 |
삼성전자주식회사 |
항 Her3 scFv 단편 및 이를 포함하는 항 c-Met/항 Her3 이중 특이 항체
|
|
HUE045065T2
(hu)
|
2014-01-31 |
2019-12-30 |
Novartis Ag |
TIM-3 antitest molekulák és felhasználásaik
|
|
MX2016009690A
(es)
|
2014-02-03 |
2017-03-03 |
Nat Cancer Ct |
Anticuerpos monoclonal anti-factor de tejido.
|
|
FR3021970B1
(fr)
|
2014-06-06 |
2018-01-26 |
Universite Sciences Technologies Lille |
Anticorps dirige contre la galectine 9 et inhibiteur de l'activite suppressive des lymphocytes t regulateurs
|
|
MD4733C1
(ro)
|
2014-08-19 |
2021-07-31 |
Merck Sharp & Dohme Corp |
Anticorpi anti-TIGIT
|
|
DK3186283T3
(da)
|
2014-08-29 |
2020-03-02 |
Hoffmann La Roche |
Kombinationsbehandling med tumormålrettede IL-2- immuncytokinervarianter og antistoffer mod humant PD-L1
|
|
CA2972048C
(en)
|
2014-12-22 |
2023-03-07 |
The Rockefeller University |
Anti-mertk agonistic antibodies and uses thereof
|
|
WO2016154585A1
(en)
|
2015-03-26 |
2016-09-29 |
Charles Sentman |
Anti-mica antigen binding fragments, fusion molecules, cells which express and methods of using
|
|
CN108064245A
(zh)
|
2015-04-17 |
2018-05-22 |
埃尔萨里斯生物技术公司 |
抗Tyro3抗体及其用途
|
|
KR101778439B1
(ko)
|
2015-04-27 |
2017-09-14 |
울산대학교 산학협력단 |
자연살해세포 활성화제를 유효성분으로 함유하는 면역증강 및 항암활성증진용 조성물
|
|
US10723793B2
(en)
|
2015-06-12 |
2020-07-28 |
Ludwig Institute For Cancer Research, Ltd. |
TGF-β3 specific antibodies and methods and uses thereof
|
|
PT3328894T
(pt)
|
2015-08-06 |
2019-02-13 |
Agency Science Tech & Res |
Anticorpos de cadeia comum gama/il2rbeta
|
|
JP6931228B2
(ja)
|
2015-09-11 |
2021-09-01 |
ワイズ・エー・シー株式会社 |
抗ｃｄ２６抗体と他の抗癌剤とを組み合わせた癌治療用組成物
|
|
PE20181046A1
(es)
|
2015-09-25 |
2018-07-03 |
Genentech Inc |
Anticuerpos anti-tigit y metodos de uso
|
|
EP3373970A4
(en)
|
2015-11-13 |
2019-07-10 |
Dana Farber Cancer Institute, Inc. |
NKG2D IG FUSION PROTEIN FOR CANCER IMMUNOTHERAPY
|
|
AU2017219254B2
(en)
|
2016-02-17 |
2019-12-12 |
Novartis Ag |
TGFbeta 2 antibodies
|
|
CA3015619A1
(en)
|
2016-03-01 |
2017-09-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Antibodies specific to human poliovirus receptor (pvr)
|
|
WO2017189526A1
(en)
|
2016-04-25 |
2017-11-02 |
Musc Foundation For Research Development |
Activated cd26-high immune cells and cd26-negative immune cells and uses thereof
|
|
DK3523416T3
(da)
|
2016-10-05 |
2025-03-03 |
Univ Central Florida Res Found Inc |
Fremgangsmåder og sammensætninger relateret til nk-celle- og anti-pdl1-kræftbehandlinger
|
|
EP4613776A3
(en)
|
2016-10-21 |
2025-11-26 |
Altor BioScience Corporation |
Multimeric il-15-based molecules
|
|
US20210230221A1
(en)
|
2017-01-03 |
2021-07-29 |
Bioatla, Llc |
Protein therapeutics for treatment of senescent cells
|
|
TWI787230B
(zh)
|
2017-01-20 |
2022-12-21 |
法商賽諾菲公司 |
抗ＴＧＦ-β抗體及其用途
|
|
AU2018226526B2
(en)
|
2017-02-28 |
2025-03-13 |
Affimed Gmbh |
Combination of an anti-CD16A antibody with a cytokine
|
|
KR102867975B1
(ko)
|
2017-03-06 |
2025-10-14 |
알토 바이오사이언스 엘엘씨 |
Il-12 및 il-18로의 il-15-기반 융합
|
|
KR20190126182A
(ko)
|
2017-03-27 |
2019-11-08 |
난트셀, 인크. |
aNK 및 IL-12 조성물 및 방법 (ANK AND IL-12 COMPOSITIONS AND METHODS)
|
|
EP3421607A1
(en)
|
2017-06-29 |
2019-01-02 |
Fundación Centro Nacional de Investigaciones Oncológicas Carlos III |
Identification and elimination of damaged and/or senescent cells
|
|
JP2020533971A
(ja)
|
2017-08-28 |
2020-11-26 |
アルター・バイオサイエンス・コーポレーション |
Ｉｌ−１５をベースとするｉｌ−７及びｉｌ−２１への融合物
|
|
EP3843788A1
(en)
|
2018-08-30 |
2021-07-07 |
HCW Biologics, Inc. |
Single-chain chimeric polypeptides and uses thereof
|
|
CN112996805A
(zh)
|
2018-08-30 |
2021-06-18 |
Hcw生物科技公司 |
多链嵌合多肽和其用途
|
|
CN120365435A
(zh)
|
2018-08-30 |
2025-07-25 |
免疫生物公司 |
单链嵌合多肽和多链嵌合多肽以及其用途
|
|
JP7713393B2
(ja)
|
2019-06-21 |
2025-07-25 |
イミュニティーバイオ インコーポレイテッド |
多鎖キメラポリペプチドおよびその使用
|
|
EP4103599A1
(en)
|
2020-02-11 |
2022-12-21 |
HCW Biologics, Inc. |
Methods of activating regulatory t cells
|
|
KR20220140535A
(ko)
|
2020-02-11 |
2022-10-18 |
에이치씨더블유 바이올로직스, 인크. |
크로마토그래피 수지 및 이의 용도
|
|
US12115191B2
(en)
|
2020-02-11 |
2024-10-15 |
Immunitybio, Inc. |
Methods of treating age-related and inflammatory diseases
|
|
US12024545B2
(en)
|
2020-06-01 |
2024-07-02 |
HCW Biologics, Inc. |
Methods of treating aging-related disorders
|
|
EP4507711A1
(en)
|
2022-04-13 |
2025-02-19 |
ImmunityBio, Inc. |
Multi-chain chimeric polypeptide for use in the treatment of treating neuroinflammatory disorder
|